Advertisement

Topics

FDA orphan status given to Syntimmune's pemphigus candidate

05:59 EDT 14 Sep 2018 | SmartBrief

Syntimmune's pemphigus candidate SYNT001 received orphan drug status from the FDA.  -More

Original Article: FDA orphan status given to Syntimmune's pemphigus candidate

NEXT ARTICLE

More From BioPortfolio on "FDA orphan status given to Syntimmune's pemphigus candidate"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...